Profil
Gunilla Anders Ekström is the founder of Gesynta Pharma AB, founded in 2017, holding the title VP-Project Management.
Current jobs include Director at NovaSAID AB, Director at Disruptive Materials AB, Independent Non-Executive Director at Corline Biomedical AB since 2017, Independent Director at Emplicure AB since 2015, Independent Director at Initiator Pharma A since 2022, Director at Haracon AB, Director at Disruptive Pharma AB since 2021, Director at Strike Pharma AB since 2021, Associate Professor at Karolinska Institutet, and Vice President-Research & Development at AnaMar AB since 2003.
Former jobs include Chief Executive Officer & Director at Biosergen AS, Chief Executive Officer at Immuneed AB, Director at Athera Biotechnologies AB, Director at Lipidor AB, Director at Palette Life Sciences AB, Product Director at Analgesia Partnership, Independent Director at Gabather AB, Director at SP Process Development AB, Member-Therapeutical Area Neurosciences at AstraZeneca AB, SVP-Project & Portfolio Management at Orexo AB from 2008 to 2013, and Vice President-Operations at KDventures AB. Education includes a doctorate from Karolinska Institutet.
Postes actifs de Gunilla Anders Ekström
| Sociétés | Poste | Début |
|---|---|---|
| CORLINE BIOMEDICAL AB | Directeur/Membre du Conseil | 01/01/2017 |
| EMPLICURE AB (PUBL) | Directeur/Membre du Conseil | 01/01/2015 |
| INITIATOR PHARMA A/S | Directeur/Membre du Conseil | 01/01/2022 |
AnaMar AB
AnaMar AB BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops novel medicine to prevent, heal and slow organ scarring of fibrotic disease | Directeur Technique/Scientifique/R&D | 01/01/2003 |
Strike Pharma AB
Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that engages in development of immunotherapeutic treatments | Directeur/Membre du Conseil | 01/05/2021 |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures novel oral treatments for patients with chronic inflammatory conditions | Fondateur | 01/01/2017 |
Disruptive Materials AB
Disruptive Materials AB Chemicals: Major DiversifiedProcess Industries Manufactures meso-porous magnesium carbonate | Directeur/Membre du Conseil | - |
Haracon AB
Haracon AB Miscellaneous Commercial ServicesCommercial Services Provides corporate consulting services | Directeur/Membre du Conseil | - |
NovaSAID AB
NovaSAID AB Pharmaceuticals: MajorHealth Technology Develops treatments for inflammation and pain in conditions such as rheumatoid arthritis | Directeur/Membre du Conseil | - |
| ░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Anciens postes connus de Gunilla Anders Ekström
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Gunilla Anders Ekström
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orexo AB
Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
AnaMar AB
AnaMar AB BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops novel medicine to prevent, heal and slow organ scarring of fibrotic disease | Health Technology |
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Operates as a biotechnology company which develops antifungal drugs for the treatment of severe invasive fungal infections | Health Technology |
Lipidor AB
Lipidor AB Miscellaneous Commercial ServicesCommercial Services Develops and commercializes lipid-based topical medication products | Commercial Services |
NovaSAID AB
NovaSAID AB Pharmaceuticals: MajorHealth Technology Develops treatments for inflammation and pain in conditions such as rheumatoid arthritis | Health Technology |
Karolinska Development AB
Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
Palette Life Sciences AB
Palette Life Sciences AB Medical SpecialtiesHealth Technology Develops products that improve the quality of life for patients | Health Technology |
Analgesia Partnership | |
Disruptive Materials AB
Disruptive Materials AB Chemicals: Major DiversifiedProcess Industries Manufactures meso-porous magnesium carbonate | Process Industries |
Gabather AB
Gabather AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops mental health drugs | Health Technology |
Corline Biomedical AB
Corline Biomedical AB Medical SpecialtiesHealth Technology Manufactures and markets heparin | Health Technology |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Develops drugs | Health Technology |
Emplicure AB
Emplicure AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for chronic pains | Health Technology |
SP Process Development AB | |
Initiator Pharma A/S
Initiator Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs to unmet medical needs within the central & peripheral nervous system | Health Technology |
Haracon AB
Haracon AB Miscellaneous Commercial ServicesCommercial Services Provides corporate consulting services | Commercial Services |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures novel oral treatments for patients with chronic inflammatory conditions | Health Technology |
Disruptive Pharma AB
Disruptive Pharma AB BiotechnologyHealth Technology Manufactures pharmaceuticals | Health Technology |
Strike Pharma AB
Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that engages in development of immunotherapeutic treatments | Commercial Services |
















